New approaches needed to improve visual accessibility for people with low vision-challenges

New approaches and tools are needed to improve visual accessibility for people with low vision in the "real world," according to a special article in the July issue of , official journal of the the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Vision science, in collaboration with other professions, has a key role in developing technologies and design approaches to promote visual accessibility for the millions of people living with low vision, according to the review by Gordon E. Legge, PhD, of University of Minnesota. In recognition of his pioneering work on low-vision research and visual accessibility, Dr Legge was named the 2013 Charles F. Prentice Award Lecture Medalist.

Visual accessibility for people with low vision-challenges and new approaches

Low vision is defined as chronically impaired vision that is not correctable by glasses or contact lenses and adversely affects everyday functioning. It is estimated that there are between 3.5 million and 5 million Americans with low vision, and this number is expected to increase as the population ages.

In his Prentice Lecture, Dr Legge-himself a person with low vision-proposes to "embed low-vision research more explicitly in the real world" in order to reduce barriers to visual accessibility, He shares examples of his research in two key areas: architectural accessibility and reading accessibility.

Architectural design can enhance visual accessibility for people with low vision. Dr Legge gives illustrated examples of how low vision can make it difficult to navigate architectural spaces; the obstacles and hazards may even change with the light at different times of day.

His research includes the development of software tools to promote the design of visually accessible spaces. These tools help in representing the impact of reduced visual acuity and contrast sensitivity, as well as predicting whether architectural features can be seen by people with low vision. Dr Legge writes, "We need practical models of low vision capable of predicting real-world object visibility."

Dr Legge's work also includes efforts to increase reading accessibility for people with low vision. Advances such as electronic readers provide powerful new tools to improve reading accessibility, but there's still a lack of knowledge of how best to use the features they provide. Research is needed to understand the interacting effects of variables such as display geometry, visual acuity, viewing distance, print size, and font.

Dr Legge urges low-vision researchers to work with other disciplines-including software and hardware developers and design professionals-toward solving the problems of visual accessibility. He writes, "Where we succeed, we will contribute to vision science by showing how vision functions in the real world, and we will find better ways to reduce barriers facing people with visual impairment."

For his outstanding history of insights and research in the field of low vision, Dr Legge was named winner of the American Academy of Optometry's Charles F. Prentice Medal for 2013. Established in 1958, the Charles F. Prentice Medal is awarded annually to an outstanding scientist who has contributed significantly to the advancement of knowledge in the visual sciences.

"Visual accessibility makes an environment, device, or display useable by those with low vision, comments Anthony Adams, OD, PhD, Editor-in-Chief of Optometry and Vision Science. "Our Prentice medalist is a world research leader in low vision and he gives us clear insight into the ways vision science plays an important role in enhancing visual accessibility for people with low vision."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Antibiotic activity altered by interaction with nanoplastics, new research shows